(Q26783545)

The Journal of Antibiotics

inferred from page(s)

published in

6 references

20 June 2019

22 June 2019

19 September 2019

11 September 2020

2 October 2020

21 January 2021

69

0 references

issue

2

0 references

page(s)

73-88

0 references

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

6 references

20 June 2019

22 June 2019

19 September 2019

11 September 2020

2 October 2020

A new antibiotic kills pathogens without detectable resistance

21 January 2021

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Combating antimicrobial resistance: policy recommendations to save lives

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

A breakthrough in R&D; for neglected diseases: new ways to get the drugs we need

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Finding cures for tropical diseases: is open source an answer?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Antibiotic resistance in bacteria associated with food animals: a United States perspective of livestock production

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Project BioShield: what it is, why it is needed, and its accomplishments so far

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Drugs for bad bugs: confronting the challenges of antibacterial discovery

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Repairing the broken market for antibiotic innovation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

New business models for antibiotic innovation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Investigational antimicrobial agents of 2013.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Antibiotics in the clinical pipeline in 2013.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

The true cost of antimicrobial resistance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Towards new business models for R&D for novel antibiotics.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Trends in risks associated with new drug development: success rates for investigational drugs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Drug development for neglected diseases - the trouble with FDA review vouchers.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

The risk we bear: the effects of review speed and industry user fees on new drug safety

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Innovation - drugs and diagnostics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Can open-source R&D reinvigorate drug research?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Impact of antibiotic restrictions: the pharmaceutical perspective

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Can biotech deliver new antibiotics?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Why is big Pharma getting out of antibacterial drug discovery?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Perspectives on stimulating industrial research and development for neglected infectious diseases.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

The critical impact of time discounting on economic incentives to overcome the antibiotic market failure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775540

Stoking the antibiotic pipeline.

31 May 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2015.98

Lessons from 60 years of pharmaceutical innovation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2015.98

Will longer antimicrobial patents improve global public health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2015.98

In whose best interest? Breaching the academic-industrial wall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2015.98

Commentary: innovation policy for a new era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2015.98

Sequential development and exploitation of an exhaustible resource: do monopoly rights promote conservation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2015.98

An economic perspective on policy to reduce antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2015.98

Seven habits of highly effective global public-private health partnerships: practice and potential

21 January 2018

1 reference

12 December 2020

Immunity for immunizations: tort liability, biodefense, and Bioshield II

1 reference

12 December 2020

Experience with Medicare's new technology add-on payment program

1 reference

12 December 2020

Improving antibiotic markets for long-term sustainability

1 reference

12 December 2020

Report urges controversial 'delinkage' to foster new antibiotics

1 reference

12 December 2020

Target small firms for antibiotic innovation

1 reference

12 December 2020

Do R&D tax credits work? Evidence from a panel of countries 1979–1997

1 reference

https://api.crossref.org/works/10.1038%2FJA.2015.98

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/JA.2015.98

1 reference

Dimensions Publication ID

1027730298

0 references

1 reference

1 reference

PubMed publication ID

26464014

1 reference